Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02978716
Brief Title: Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)

First Submitted : November 18, 2016
First Submitted that Met QC Criteria : November 28, 2016
First Posted : December 1, 2016 (Estimate)

Certification/Extension First Submitted : July 18, 2019
Certification/Extension First Submitted that Met QC Criteria : July 18, 2019
Certification/Extension First Posted : July 26, 2019

Last Update Submitted that Met QC Criteria : July 18, 2019
Last Update Posted : July 26, 2019